We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.135 | -2.91% | 4.51 | 4.41 | 4.99 | 4.53 | 4.51 | 4.53 | 189,892 | 11:53:49 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 21/7/2020 07:54 | The trial of SNG001 in hospitalised COVID-19 patients is a Phase II trial ( | shirley83 | |
| 21/7/2020 07:53 | It was a phase 1 trial using a very low number of people, there is a long way to go with phase 2 and a significant increase in numbers will be needed. Nothing has been authorized or granted and it is a long long way from getting the green light as a miracle Covid cure. That's my take on the rns but all that was quite obvious yesterday anyway | supercity | |
| 21/7/2020 07:45 | Once fully approved its £30 easily best time to get in and last chance window is upon us | strongbuy | |
| 21/7/2020 07:45 | Let it settle first .... | amaretto1 | |
| 21/7/2020 07:44 | Time to top up | strongbuy | |
| 21/7/2020 07:44 | Get your tin hats on folks!!!! | barnes4 | |
| 21/7/2020 07:43 | Prevention is better than cure. | cottoner | |
| 21/7/2020 07:36 | If there is a natural drug such as SNG001 that controls and kills all respiratory viruses and illnesses it really does spoil the narrative they are pushing on a vaccine. SNG001 is natural and stops these viruses dead in the water no need for these vaccines and the multi billions we will end up paying for them. | tidy 2 | |
| 21/7/2020 07:28 | Bermuda boys will have picked them up :-) | amaretto1 | |
| 21/7/2020 07:28 | DNL =3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = 5+ BAGGER GEM Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping iant here .GL Market Cap £38 million Cash £15 million Price 30p Alkindi approval in Australia expected this Quarter Alkindi approval in Israel expected this Quarter FDA decision for Alkindi on September 29 EMA Decision for Chronocort expected in early Q1 2021 | ih_752952 | |
| 21/7/2020 07:24 | Those shares were sold on Friday not yesterday, pls read the RNS | amrishbhim |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
